7.3Overall

RxAnte

Pharmacy care management for health plans and value-based providers

RecommendScored Nov 2026

RxAnte combines adherence analytics, clinical decision support, and its Mosaic home pharmacy service to improve medication use for health plan members.

rxante.com

Best for

  • Medicare Advantage and Medicaid plans working on Star Ratings, HEDIS, and medication adherence measures
  • Plans that want analytics and a high-touch pharmacy service for their most complex members

Not ideal for

  • Employers seeking a pharmacy benefit manager or drug pricing contract
  • Buyers who expect public list pricing before a sales conversation
RxAnte homepage or product landing page

Bottom line

RxAnte is a strong option for health plans that want adherence analytics and a hands-on pharmacy service for complex members. It fits best when the plan can share data, define quality goals, and measure results with the vendor.

Score breakdown

7.8
Outcomes and workflow value
7.8
Product and service depth
7.0
Ease of implementation
5.6
Pricing clarity

Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.

RxAnte serves health plans and risk-bearing providers that want more members taking the right medicines at the right time. Arine is a direct alternative for payer medication optimization, with a similar focus on finding members whose drug use is unsafe, ineffective, or lapsing. Pharmacy benefit managers and generic outreach vendors overlap only in part.

The purchase is a pharmacy care management program, not a single software license. RxAnte scores members, recommends interventions, and can route the most complex members to Mosaic, its home pharmacy service. Buyers should compare a defined program, including outreach channels and measurement, with an equivalent program from Arine.

  • Outcomes and workflow value (7.8): A published NEJM Catalyst evaluation cited by the company and a large managed population support the outcome case, though results depend on the plan and program design.
  • Product and service depth (7.8): Adherence targeting, the VFA score, therapeutic decision support, and the Mosaic pharmacy service cover analytics and intervention.
  • Ease of implementation (7.0): Programs are configured to each plan's data and outreach channels, which takes coordinated work with care management teams.
  • Pricing clarity (5.6): No dollar pricing is published, and the commercial terms for Mosaic and analytics are set by contract.

Adherence Analytics and Targeting

RxAnte describes RxEffect as an adherence workflow used daily by more than 5,000 end users. The software flags members at risk of nonadherence and suggests the intervention most likely to help each one. Its Value of Future Adherence (VFA) score estimates how a member's adherence affects total cost of care, so plans can rank outreach by expected value.

The health plan page connects these tools to CMS Star Ratings adherence measures, HEDIS, and CAHPS. That focus suits Medicare Advantage and Medicaid plans with quality bonus exposure. Plans with different goals should confirm which models and measures apply to their population.

Mosaic Pharmacy Service

Mosaic is RxAnte's value-based home pharmacy. Eligible members receive presorted pouches of medication at home, along with medication reviews and coordination with doctors and the health plan. RxAnte reports a Net Promoter Score of 85 for the service and says Mosaic is offered at no added cost to eligible members.

The homepage cites an NEJM Catalyst study reporting $406 saved per enrolled member per month and 32% fewer inpatient stays. Results for another plan depend on how its members, data, and pharmacy network compare with the studied population.

Growth and Ownership

In January 2026 RxAnte announced a strategic growth investment from Primus Capital. The release says the company will manage more than 34 million lives in 2026 with regional and national health plans, and that UPMC has been a partner with RxAnte since 2016.

RxAnte was also listed among the Financial Times fastest-growing companies in the Americas for a second year, moving to No. 93. Growth rankings describe revenue growth, not clinical effect, but they suggest an active and expanding client base.

Product and service details: rxante.com, rxante.com.

Company scale

Similarweb's September 2026 profile estimates RxAnte annual revenue at $10 million to $15 million, with 51 to 200 employees. Scale source

What People Say

What people like

"The adherence scores told our pharmacists which members to call first, which made the outreach list manageable."

"Moving our most complex members to presorted pouches at home took a lot of pressure off our care managers."

What people don't like

"We had to work through data feeds and program design before we saw a clear picture of what the service would cost."

Where customer reviews couldn't be found, our analysts attempted to give a voice to buyer sentiment, drawing on real information from review sites, forums and product documentation.

Based on: Product or service details, Product or service details.

Competitor landscape

VendorOverallEase of implementation
RxAnte7.37.0
Arine7.57.0
Aspen RxHealth7.27.0

Pricing

ItemDetail
Commercial modelContracted pharmacy care management program; no public dollar pricing.
MosaicOffered to eligible health plan members at no added cost to the member, according to RxAnte.
Program designRxAnte simulates scenarios from plan data to size the program before launch.
Compare equivalent scopeInclude analytics, outreach channels, pharmacy services, reporting, and any performance terms.

Leadership

Recent news

Methodology

We reviewed product documentation, published service evidence, pricing, and customer accounts available on November 8, 2026. Scores are editorial assessments on a ten-point scale. The overall score weights outcomes and workflow value at 35%, product at 30%, implementation at 20%, and pricing clarity at 15%. Company-website testimonials are vendor-selected accounts.

Existing peer scores are carried from the linked HIR reviews.

Sources
  1. Healthcare Industry Reviews analysis of the product, service, and pricing sources below, conducted November 2026.
  2. rxante.com ·
  3. rxante.com · health plans
  4. similarweb.com · company/rxante.com
  5. rxante.com · mosaic by rxante
  6. rxante.com · about us
  7. rxante.com · uncategorized/rxante announces strategic growth investment from primus capital
  8. rxante.com · uncategorized/rxante recognized by the financial times as one of the americas fastest growing companies for the second consecutive year